Regional lymphadenopathy following COVID-19 vaccination: considerations for primary care management
(2021)
Journal Article
Regional lymphadenopathy has been rarely reported following the administration of vaccinations for tuberculosis, influenza, and human papillomavirus (≤1–2/100 000 vaccines).1,2 In the first months of 2021, there seems to have been an increase in the... Read More about Regional lymphadenopathy following COVID-19 vaccination: considerations for primary care management.